Evidence map›Paper›PMID 35990826›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2022

Potential Mechanisms of White Peony against Primary Sjögren's Syndrome Based on Network Pharmacology and Molecular Docking.

Shuqi Zhuang, Jincheng Pu, Yuanyuan Liang, Zhenzhen Wu, Ronglin Gao, Shengnan Pan, Jiamin Song, Jianping Tang, Xuan Wang

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Shuqi ZhuangDepartment of Rheumatology and Immunology, Tongji Hospital, School of Medicine, Tongji University, Shanghai 20065, China.ORCID https://orcid.org/0000-0002-3506-0631
Jincheng PuDepartment of Rheumatology and Immunology, Tongji Hospital, School of Medicine, Tongji University, Shanghai 20065, China.ORCID https://orcid.org/0000-0001-9242-3067
Yuanyuan LiangDepartment of Rheumatology and Immunology, Tongji Hospital, School of Medicine, Tongji University, Shanghai 20065, China.ORCID https://orcid.org/0000-0003-0360-286X
Zhenzhen WuDepartment of Rheumatology and Immunology, Tongji Hospital, School of Medicine, Tongji University, Shanghai 20065, China.ORCID https://orcid.org/0000-0003-4384-3473
Ronglin GaoDepartment of Rheumatology and Immunology, Tongji Hospital, School of Medicine, Tongji University, Shanghai 20065, China.ORCID https://orcid.org/0000-0002-4507-480X
Shengnan PanDepartment of Rheumatology and Immunology, Tongji Hospital, School of Medicine, Tongji University, Shanghai 20065, China.ORCID https://orcid.org/0000-0002-4520-0239
Jiamin SongDepartment of Rheumatology and Immunology, Tongji Hospital, School of Medicine, Tongji University, Shanghai 20065, China.ORCID https://orcid.org/0000-0001-9815-8508
Jianping TangDepartment of Rheumatology and Immunology, Tongji Hospital, School of Medicine, Tongji University, Shanghai 20065, China.ORCID https://orcid.org/0000-0003-4629-7631
Xuan WangDepartment of Rheumatology and Immunology, Tongji Hospital, School of Medicine, Tongji University, Shanghai 20065, China.ORCID https://orcid.org/0000-0002-6588-2951
Tongji University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Multiple system and organ damage occurs with the continuous progression of primary Sjögren's syndrome (pSS), and the lack of specific drugs against this disease is a huge challenge. White peony (WP), a widely used traditional Chinese herb, has been confirmed to have a therapeutic value in pSS. However, the specific mechanisms of WP in the treatment of pSS are unknown. Methods: The active ingredients and their targets in WP were searched on the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP), and disease-related targets were collected from GeneCards, Online Mendelian Inheritance in Man (OMIM), and the Therapeutic Target Database (TTD). The overlapping targets were acquired by taking the intersection. A protein-protein interaction (PPI) network was structured using the STRING database. A disease-drug-ingredient-target (D-D-I-T) network was built using Cytoscape software. By filtering twice, core targets were acquired. Gene Ontology (GO) and Kyoto Encyclopedia Gene and Genome (KEGG) pathway enrichment analysis were accompanied by R packages. Finally, molecular docking was used to verify the abovementioned results. Results: In total, we screened 88 WP-related targets, 1480 pSS-related targets, and 32 overlapping targets. D-D-I-T Network analysis displayed six main active ingredients of WP, which played a significant therapeutic role in pSS. Further topological analysis selected seven core target genes, including IL-6, TNF, PPAR Conclusion: Our study revealed that IL-6, TNF, AKT1, CASP3, NOS3, and JUN may be pathogenic target genes, and PPAR

Identifiers

PMID35990826
PMCPMC9391099
OpenAlexW4290963992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.